COMPARATIVE EFFECTIVENESS RESEARCH
Home  /  Comparative Research
Information on the relative strengths and weaknesses of various medical interventions can improve care for all Americans. Over one billion dollars in stimulus funds have been allocated to help researchers identify the most effective treatments to support medical decision making for both clinicians and patients.  
INDEPENDENT. OBJECTIVE.
Observational Data Can Inform Treatment Choices
Comparative Effectiveness Research has great potential for improving healthcare quality and patient care, while controlling costs. Determining which medical treatments have the best results requires hard evidence.

Comparing treatment options by using observational studies is timely and cost-effective. MarketScan® Research Databases can support the rigorous evaluations necessary for retrospective effectiveness studies. The MarketScan® databases allow longitudinal, patient level analyses of health and economic outcomes. Using the data, researchers can evaluate particular procedures, courses of therapy, disease states, patient populations, and settings of care. The most recent MarketScan data year features more than 41 million covered lives in 2007, providing longitudinal strength and detailed patient-level data for meaningful measures of treatment effectiveness and the costs of care.
Learn more

START BY GETTING THE FACTS
RECORDED WEB SEMINAR

Optimizing Observational Data for Comparative Effectiveness Research

Presented by Tami L. Mark, PhD, MBA, Director, Analytic Strategies

Observational studies are an important resource for comparing the real-world effectiveness of various treatment options. However, the validity of observational studies can be compromised by confounding factors and selection bias. Learn how to proactively address these issues. Click here.

ADDITIONAL RESOURCES

RESEARCH SOLUTIONS
MARKETSCAN® WHITE PAPER
CATIE CASE STUDY POSTER
COMPARATIVE EFFECTIVENESS ARTICLES
RECORDED WEB SEMINAR:
   OPTIMIZING OBSERVATIONAL DATA

DOWNLOAD LIBRARY

EXPERT SPOTLIGHT


William D. Marder, PhD
Senior Vice President and General Manager

Dr. Marder directs research and database development services for government, private research and policy development organizations, and the pharmaceutical/medical technology industry.